- Previous Close
0.1550 - Open
0.1100 - Bid 0.1000 x --
- Ask 0.1100 x --
- Day's Range
0.0900 - 0.1100 - 52 Week Range
0.0800 - 0.2800 - Volume
143,950 - Avg. Volume
25,236 - Market Cap (intraday)
28.811M - Beta (5Y Monthly) 3.08
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Nov 27, 2024 - Dec 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was incorporated in 2018 and is headquartered in Tampa, Florida.
getfluent.com--
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: TIUM-U.CN
View More
Performance Overview: TIUM-U.CN
Trailing total returns as of 2024-11-06, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TIUM-U.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TIUM-U.CN
View MoreValuation Measures
Market Cap
47.01M
Enterprise Value
147.10M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.53
Price/Book (mrq)
8.17
Enterprise Value/Revenue
1.42
Enterprise Value/EBITDA
3.59
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.81%
Return on Assets (ttm)
6.89%
Return on Equity (ttm)
-110.43%
Revenue (ttm)
103.3M
Net Income Avi to Common (ttm)
-13.23M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
8.48M
Total Debt/Equity (mrq)
1,887.97%
Levered Free Cash Flow (ttm)
-5.48M